Cargando…
Update on the strategy for intravenous fluid treatment in acute pancreatitis
Fluid therapy/resuscitation is mandatory in acute pancreatitis due to the pathophysiology of fluid loss as a consequence of the inflammatory process. For many years, without clear evidence, early and aggressive fluid resuscitation with crystalloid solutions (normal saline solution or Ringer lactate...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167805/ https://www.ncbi.nlm.nih.gov/pubmed/37179816 http://dx.doi.org/10.4292/wjgpt.v14.i3.22 |
_version_ | 1785038741395472384 |
---|---|
author | Yaowmaneerat, Thanapon Sirinawasatien, Apichet |
author_facet | Yaowmaneerat, Thanapon Sirinawasatien, Apichet |
author_sort | Yaowmaneerat, Thanapon |
collection | PubMed |
description | Fluid therapy/resuscitation is mandatory in acute pancreatitis due to the pathophysiology of fluid loss as a consequence of the inflammatory process. For many years, without clear evidence, early and aggressive fluid resuscitation with crystalloid solutions (normal saline solution or Ringer lactate solution) was recommended. Recently, many randomized control trials and meta-analyses on fluid therapy have revealed that high fluid rate infusion is associated with increased mortality and severe adverse events compared to those resulting from moderate fluid rates, and this has triggered a paradigm shift in fluid management strategies. Meanwhile, there is evidence to show that Ringer lactate solution is superior to normal saline solutions in this context. The purpose of this review is to provide an update on the strategies for intravenous fluid treatment in acute pancreatitis, including the type, optimal amount, rate of infusion, and monitoring guides. Recommendations from recent guidelines are critically evaluated for this review in order to reach the authors' recommendations based on the available evidence. |
format | Online Article Text |
id | pubmed-10167805 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-101678052023-05-10 Update on the strategy for intravenous fluid treatment in acute pancreatitis Yaowmaneerat, Thanapon Sirinawasatien, Apichet World J Gastrointest Pharmacol Ther Minireviews Fluid therapy/resuscitation is mandatory in acute pancreatitis due to the pathophysiology of fluid loss as a consequence of the inflammatory process. For many years, without clear evidence, early and aggressive fluid resuscitation with crystalloid solutions (normal saline solution or Ringer lactate solution) was recommended. Recently, many randomized control trials and meta-analyses on fluid therapy have revealed that high fluid rate infusion is associated with increased mortality and severe adverse events compared to those resulting from moderate fluid rates, and this has triggered a paradigm shift in fluid management strategies. Meanwhile, there is evidence to show that Ringer lactate solution is superior to normal saline solutions in this context. The purpose of this review is to provide an update on the strategies for intravenous fluid treatment in acute pancreatitis, including the type, optimal amount, rate of infusion, and monitoring guides. Recommendations from recent guidelines are critically evaluated for this review in order to reach the authors' recommendations based on the available evidence. Baishideng Publishing Group Inc 2023-05-05 2023-05-05 /pmc/articles/PMC10167805/ /pubmed/37179816 http://dx.doi.org/10.4292/wjgpt.v14.i3.22 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Minireviews Yaowmaneerat, Thanapon Sirinawasatien, Apichet Update on the strategy for intravenous fluid treatment in acute pancreatitis |
title | Update on the strategy for intravenous fluid treatment in acute pancreatitis |
title_full | Update on the strategy for intravenous fluid treatment in acute pancreatitis |
title_fullStr | Update on the strategy for intravenous fluid treatment in acute pancreatitis |
title_full_unstemmed | Update on the strategy for intravenous fluid treatment in acute pancreatitis |
title_short | Update on the strategy for intravenous fluid treatment in acute pancreatitis |
title_sort | update on the strategy for intravenous fluid treatment in acute pancreatitis |
topic | Minireviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167805/ https://www.ncbi.nlm.nih.gov/pubmed/37179816 http://dx.doi.org/10.4292/wjgpt.v14.i3.22 |
work_keys_str_mv | AT yaowmaneeratthanapon updateonthestrategyforintravenousfluidtreatmentinacutepancreatitis AT sirinawasatienapichet updateonthestrategyforintravenousfluidtreatmentinacutepancreatitis |